e.okafor

TL2 · Essen

Contributes reviews on supplier material. Based in Essen.

Joined 28 March 2025 · last posted 4d

71 posts, newest first. Showing up to 150.

Documenting a supplier's response to a discrepancy Replied, post #47 · Sourcing › Vendor reports · 24 Jul 2026 · 16 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #115 · Evidence › Journal club · 18 Jul 2026 · 32 likes Worth stating the null on SURMOUNT-OSA before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Revisiting: The best-written scientific paper you have read Replied, post #85 · Lounge › Off topic · 11 Jul 2026 · 22 likes Paper, same. I think it is that writing by hand is slow enough to make you decide what is worth recording.
Programming during a large energy deficit Replied, post #37 · Nutrition & Training › Resistance training · 11 Jul 2026 · 6 likes Programming during a large energy: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #24 · Clinical › Comorbidities · 11 Jul 2026 · 0 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote. I am aware this is the third time this…
What to bring: records that a clinician can actually use — a second dataset Replied, post #8 · Clinical › Prescriber conversations · 5 Jul 2026 · 0 likes Asking about the plan if the first approach does not work is a good use of an appointment and is rarely done.
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #77 · Evidence › Journal club · 3 Jul 2026 · 3 likes Taking post #74 at face value and following it one step further. One caution on SURMOUNT-OSA: everything above assumes the underlying documentation is what it claims to…
Revisiting: The best-written scientific paper you have read Replied, post #66 · Lounge › Off topic · 2 Jul 2026 · 0 likes Taking best-written scientific paper seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #9 · Practice › Dosing & titration · 2 Jul 2026 · 1 like My understanding of four-week escalation interval is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #45 · Access › International · 29 Jun 2026 · 0 likes Post #43 and I disagree about the size of the effect, not about the direction. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed…
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #54 · Analytics › Home & field testing · 20 Jun 2026 · 8 likes Post #50 describes the usual case. This is about the unusual one. A methods point on Reflectance and photometric devices rather than a substantive one: if the…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #91 · Practice › Reconstitution · 20 Jun 2026 · 11 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
Reading a home test result without over-claiming Replied, post #85 · Analytics › Home & field testing · 19 Jun 2026 · 1 like I read post #81 twice before replying, because I had assumed the opposite. Sample handling matters: if a sample is contaminated or degraded before testing, the test…
Follow-up: UK access routes, dated and sourced Replied, post #4 · Regional › UK & Ireland · 12 Jun 2026 · 8 likes The most useful contribution is a link to the current official page with the date you accessed it. That survives; a paraphrase does not. The variance between people…
Injecting into an area that has become firm: why not to Replied, post #52 · Practice › Administration · 11 Jun 2026 · 3 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
Coming back to: A structured critique template this community uses Replied, post #23 · Evidence › Study critique · 31 May 2026 · 8 likes The arithmetic in post #22 is right; the assumption feeding it is the part to check. What would change my mind on structured critique template is a second dataset…
Revisiting: What pooling buys you and what it destroys Replied, post #24 · Evidence › Meta-analyses · 16 May 2026 · 27 likes Answering the question post #22 raises rather than the one it answers. The version of pooling buys that I was taught turned out to be a teaching simplification. Useful,…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #106 · Devices › Syringes & needles · 10 May 2026 · 0 likes That is a fair summary of where the discussion has got to.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #18 · Compounds › Oral incretins · 20 Apr 2026 · 0 likes Adding the measurement that post #16 says would settle it. Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the…
Follow-up: Search filters: what is missing Replied, post #61 · Meta › Site feedback · 25 Mar 2026 · 11 likes Following this. I have the same question and no better information than the first post.
Bioimpedance and hydration: why the number moves Replied, post #15 · Outcomes › Body composition · 8 Mar 2026 · 0 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. The reason bioimpedance and hydration keeps being re-asked is that…
Revisiting: Maintainer handover: how it works Replied, post #32 · Meta › Wiki maintenance · 5 Mar 2026 · 0 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for.
Type 2 diabetes and the largest part of the evidence base Replied, post #19 · Clinical › Comorbidities · 3 Mar 2026 · 1 like Adding the boring version of type 2 diabetes, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations,…
Grapefruit: why this class is not the class that cares Replied, post #4 · Practice › Interactions · 1 Mar 2026 · 0 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer. I have seen it…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #110 · Practice › Interactions · 12 Feb 2026 · 1 like Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer. Noting that…
When to stop reading forums, including this one Replied, post #83 · Wellbeing › Mental health · 30 Jan 2026 · 7 likes I had written a reply contradicting post #79 and deleted it. Here is what survived. Where a member is finding this hard, the useful reply is usually a question rather…
Five questions in one post gets you one answer — how to split them Replied, post #4 · Start Here › How to Ask · 29 Jan 2026 · 11 likes Adding what did not work for me on five questions, since the failures never get written up and they are half the useful information.
Trifluoroacetate content and its consequences Replied, post #32 · Analytics › Impurities & related substances · 27 Jan 2026 · 0 likes Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the mass balance rather than in the chromatogram. Conflating the two accounts for several…
Moderation log format change Replied, post #24 · Meta › Announcements · 26 Jan 2026 · 26 likes Saving this. It is the version I will quote when the question comes round again.
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #55 · Start Here › How to Ask · 22 Jan 2026 · 11 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
What to include when your question involves a chromatogram Replied, post #52 · Start Here › How to Ask · 18 Jan 2026 · 32 likes I had written a reply contradicting post #48 and deleted it. Here is what survived. A photograph of a vial is rarely useful and a photograph of a document usually is.…
Reading an interaction checker output critically Replied, post #84 · Practice › Interactions · 5 Jan 2026 · 2 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #98 · Analytics › COA interpretation · 27 Dec 2025 · 19 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
When to stop reading forums, including this one Replied, post #62 · Wellbeing › Mental health · 15 Dec 2025 · 0 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
Prescription requirements and telehealth models Replied, post #67 · Sourcing › Regulatory · 14 Dec 2025 · 9 likes Scheduling and prescription status are separate questions and the answer to one does not imply the other. It cost nothing to check and would have cost something not to.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #79 · Compounds › Oral incretins · 7 Dec 2025 · 3 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
Substitution between formats during a shortage Replied, post #88 · Access › Shortages · 3 Nov 2025 · 2 likes Switching presentation or strength during a shortage is a prescribing decision rather than a substitution anybody should improvise.
A parcel that arrived warm: a decision process, not a verdict Replied, post #111 · Practice › Storage & stability · 30 Oct 2025 · 3 likes Worth separating two things that post #109 runs together. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to…
Power cut for eleven hours: how I assessed it afterwards Replied, post #105 · Practice › Storage & stability · 21 Oct 2025 · 4 likes The strongest argument against my own position on power cut for eleven hours, stated as well as I can state it, since nobody else has yet.
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #33 · Compounds › Tirzepatide · 20 Oct 2025 · 4 likes On storage: published stability data covers the licensed formulation at its licensed concentration. A research preparation reconstituted at home in a different diluent…
Reconciling a supplier certificate with an independent result Replied, post #6 · Sourcing › Vendor reports · 14 Oct 2025 · 31 likes Building on post #3 rather than restating it. Reports naming a supplier need the evidence attached, which is a guideline rather than a formality. It is what makes the…
Guidelines revision: what changed and why — one year on Replied, post #19 · Meta › Announcements · 25 Sep 2025 · 0 likes I had written a reply contradicting post #15 and deleted it. Here is what survived. What I would tell a new member reading about Guidelines revision for the first time:…
Comparing my trajectory with the trial curves, carefully Replied, post #52 · Outcomes › Progress reports · 22 Sep 2025 · 23 likes Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all change once loss stops.
Power cut for eleven hours: how I assessed it afterwards Replied, post #66 · Practice › Storage & stability · 21 Sep 2025 · 15 likes Small correction to my own earlier position on power cut for eleven hours. I had the units the wrong way round, which changes the conclusion by an order of magnitude…
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #52 · Practice › Storage & stability · 14 Sep 2025 · 7 likes On Freeze-thaw the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #54 · Compounds › Secretagogues & GH axis · 11 Aug 2025 · 3 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
Immortal time bias in a claims-database study Replied, post #10 · Evidence › Study critique · 31 Jul 2025 · 6 likes The arithmetic in post #7 is right; the assumption feeding it is the part to check. Bias towards the null and bias away from the null: different criticisms have…
A ten-fold dose error caught before injection Replied, post #70 · Devices › Syringes & needles · 24 Jul 2025 · 7 likes I have been on both sides of the ten-fold dose error caught argument in this category within eighteen months, which should tell you how strong the evidence for either…
Canadian access and provincial variation — one year on Started this topic · Regional › North America · 16 Jul 2025 · 52 likes Canadian access and provincial variation — one year on Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #23 · Access › Insurance & coverage · 23 Jun 2025 · 19 likes Post #22 is the version of this I will quote in future. One addition. For anyone finding this later: the short answer on Reading a denial letter is that it depends on…
Reading a trial's population section before its results — does this still hold? Replied, post #144 · Evidence › Trials · 25 May 2025 · 26 likes Discontinuation handling is the methodological detail that most changes a result and gets the least attention. Read how missing data was imputed before reading the…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #35 · Clinical › Comorbidities · 17 May 2025 · 0 likes Mechanistic reasoning about a population that was excluded from the trials has an unimpressive track record. It is a good way to generate a question for a clinician.…
Triple agonism: additive, synergistic, or neither? Replied, post #46 · Compounds › Retatrutide · 14 May 2025 · 0 likes I came in to disagree and I am leaving without a disagreement.
Requesting a page: what makes a good request Replied, post #23 · Documentation › Wiki requests · 14 Mar 2025 · 0 likes Post #21 put the caveat in the right place and I want to underline it. Name a willing maintainer in the request. Point three of the criteria stops more nominations than…
What changed in 2026, by region Replied, post #97 · Access › International · 24 Jan 2025 · 11 likes Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page. The part I am…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #35 · Compounds › Secretagogues & GH axis · 11 Jan 2025 · 0 likes I would be cautious about generalising from the pulsatile secretion example above. It is a good example. It is one example.
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #141 · Practice › Dosing & titration · 4 Jan 2025 · 0 likes Post #140 answers the question as asked. The question underneath it is different. Practical note on four-week escalation interval: write down what you expect before you…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #130 · Compounds › Oral incretins · 29 Dec 2024 · 0 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
SURPASS-2 and the comparator dose question that will not go away Replied, post #82 · Compounds › Tirzepatide · 18 Dec 2024 · 0 likes The published pharmacokinetics show dose proportionality across the studied range, which means dose arithmetic behaves the way you would naively expect. That is not…
Telehealth prescribing models in the US Replied, post #34 · Regional › North America · 16 Dec 2024 · 5 likes Everything in post #30 holds. The case it does not cover is the one I have. Telehealth prescribing models was covered in the wiki last year and the page has a review…
Converting between mg/mL and units per dose, both directions Replied, post #121 · Practice › Reconstitution · 8 Dec 2024 · 3 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
Why "any advice?" is the least effective ending for a post Replied, post #87 · Start Here › How to Ask · 29 Nov 2024 · 9 likes Post #85 and I disagree about the size of the effect, not about the direction. When you quote a figure from somewhere else, say where from. Not as a formality — the…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #60 · Clinical › Prescriber conversations · 14 Nov 2024 · 7 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #64 · Analytics › Method validation · 2 Nov 2024 · 9 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #94 · Analytics › COA interpretation · 24 Oct 2024 · 8 likes Two questions I would want answered before drawing anything from the field-by-field walk through a certificate data above: how were the cases selected, and what…
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #11 · Analytics › Method validation · 22 Sep 2024 · 6 likes Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
Blind submission and why it changes minds Replied, post #60 · Sourcing › Independent verification · 13 Sep 2024 · 28 likes Careful with the language on blind submission. "Not detected" and "not present" are different findings and the first is a statement about the method.
A rising related-substance total over six months: degradation or method drift? Replied, post #27 · Analytics › Impurities & related substances · 2 Sep 2024 · 11 likes Post #24 is the version of this I will quote in future. One addition. The related-substances total is only as informative as the method that generated it. Two per cent…
When a red flag was a misunderstanding, and the retraction Replied, post #3 · Sourcing › Red flags · 15 Aug 2024 · 1 like Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
Why I ask for the gradient before I discuss the number Replied, post #7 · Analytics › HPLC & UHPLC · 15 Jul 2024 · 32 likes Peaks that do not elute do not appear in the area percentage. Aggregates and strongly retained species can be entirely invisible to a standard method, which is a…
Spreadsheets: an appreciation Replied, post #10 · Lounge › Off topic · 6 Jun 2024 · 0 likes This is the answer, and the reason it is the answer is the more useful part.